IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Biomark Capital Management Co. LLC

Q3 2017 Holdings

Filed 2017-10-30 | 3 holdings | $4.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Adma Biologics, Inc.(ADMA)COM000899104$4.4M1,433,30498.1%
Juno Therapeutics, Inc.COM48205A109$83.6K1,864,1741.9%
Mabvax Therapeutics Holdings, Inc.COM NEW55414P504$1726,7080.0%